Pulse Biosciences (NASDAQ:PLSE) Shares Gap Down to $17.54

Pulse Biosciences, Inc. (NASDAQ:PLSE)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $17.54, but opened at $16.37. Pulse Biosciences shares last traded at $16.55, with a volume of 4,945 shares trading hands.

Analysts Set New Price Targets

Separately, StockNews.com raised Pulse Biosciences to a “sell” rating in a research note on Friday, September 20th.

Pulse Biosciences Trading Up 2.0 %

The stock has a market cap of $932.20 million, a price-to-earnings ratio of -20.43 and a beta of 1.75. The stock has a 50-day moving average price of $17.58 and a two-hundred day moving average price of $12.98.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the company. Rhumbline Advisers grew its stake in Pulse Biosciences by 6.7% in the 2nd quarter. Rhumbline Advisers now owns 25,729 shares of the company’s stock valued at $288,000 after acquiring an additional 1,608 shares during the last quarter. BNP Paribas Financial Markets lifted its stake in shares of Pulse Biosciences by 63.6% during the first quarter. BNP Paribas Financial Markets now owns 7,597 shares of the company’s stock worth $66,000 after purchasing an additional 2,952 shares in the last quarter. Quest Partners LLC acquired a new stake in Pulse Biosciences during the 2nd quarter valued at $91,000. Bank of New York Mellon Corp boosted its holdings in Pulse Biosciences by 23.4% in the second quarter. Bank of New York Mellon Corp now owns 50,914 shares of the company’s stock valued at $570,000 after purchasing an additional 9,639 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD acquired a new position in Pulse Biosciences during the 1st quarter worth $88,000. 76.95% of the stock is currently owned by institutional investors and hedge funds.

Pulse Biosciences Company Profile

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.